Pharmaceutical Contract Development and Manufacturing-Global Market Status and Trend Report 2013-2023
Report Summary
Pharmaceutical Contract Development and Manufacturing-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Contract Development and Manufacturing industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Pharmaceutical Contract Development and Manufacturing 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Contract Development and Manufacturing worldwide, with company and product introduction, position in the Pharmaceutical Contract Development and Manufacturing market
Market status and development trend of Pharmaceutical Contract Development and Manufacturing by types and applications
Cost and profit status of Pharmaceutical Contract Development and Manufacturing, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Contract Development and Manufacturing market as:
Global Pharmaceutical Contract Development and Manufacturing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Pharmaceutical Contract Development and Manufacturing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Big Pharma
Small Pharma
Generic Pharma
CRO
Global Pharmaceutical Contract Development and Manufacturing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Contract Development and Manufacturing Sales Volume, Revenue, Price and Gross Margin):
AbbVie Inc.
Aenova Group
Recipharm AB
Catalent, Inc.
Thermo Fisher Scientific Inc.
Lonza Group Ltd
Almac Group
FAMAR Health Care Services
Vetter Pharma International GMBH
Consort Medical plc
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmaceutical Contract Development and Manufacturing-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Contract Development and Manufacturing industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Pharmaceutical Contract Development and Manufacturing 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Contract Development and Manufacturing worldwide, with company and product introduction, position in the Pharmaceutical Contract Development and Manufacturing market
Market status and development trend of Pharmaceutical Contract Development and Manufacturing by types and applications
Cost and profit status of Pharmaceutical Contract Development and Manufacturing, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Contract Development and Manufacturing market as:
Global Pharmaceutical Contract Development and Manufacturing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Pharmaceutical Contract Development and Manufacturing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Big Pharma
Small Pharma
Generic Pharma
CRO
Global Pharmaceutical Contract Development and Manufacturing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Contract Development and Manufacturing Sales Volume, Revenue, Price and Gross Margin):
AbbVie Inc.
Aenova Group
Recipharm AB
Catalent, Inc.
Thermo Fisher Scientific Inc.
Lonza Group Ltd
Almac Group
FAMAR Health Care Services
Vetter Pharma International GMBH
Consort Medical plc
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
1.1 Definition of Pharmaceutical Contract Development and Manufacturing in This Report
1.2 Commercial Types of Pharmaceutical Contract Development and Manufacturing
1.2.1 Pharmaceutical Manufacturing Services
1.2.2 Biologics Manufacturing Services
1.2.3 Drug Development Services
1.3 Downstream Application of Pharmaceutical Contract Development and Manufacturing
1.3.1 Big Pharma
1.3.2 Small Pharma
1.3.3 Generic Pharma
1.3.4 CRO
1.4 Development History of Pharmaceutical Contract Development and Manufacturing
1.5 Market Status and Trend of Pharmaceutical Contract Development and Manufacturing 2013-2023
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Contract Development and Manufacturing 2013-2017
2.2 Production Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Regions
2.3 Demand Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.4 Production and Demand Status of Pharmaceutical Contract Development and Manufacturing by Regions
2.4.1 Production and Demand Status of Pharmaceutical Contract Development and Manufacturing by Regions 2013-2017
2.4.2 Import and Export Status of Pharmaceutical Contract Development and Manufacturing by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Types
3.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Types
3.3 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
4.2 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
5.1 Global Economy Situation and Trend Overview
5.2 Pharmaceutical Contract Development and Manufacturing Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.3 Basic Information of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
6.3.2 Employees and Revenue Level of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 AbbVie Inc.
7.1.1 Company profile
7.1.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.1.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of AbbVie Inc.
7.2 Aenova Group
7.2.1 Company profile
7.2.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.2.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Aenova Group
7.3 Recipharm AB
7.3.1 Company profile
7.3.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.3.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Recipharm AB
7.4 Catalent, Inc.
7.4.1 Company profile
7.4.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.4.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Catalent, Inc.
7.5 Thermo Fisher Scientific Inc.
7.5.1 Company profile
7.5.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.5.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
7.6 Lonza Group Ltd
7.6.1 Company profile
7.6.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.6.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Lonza Group Ltd
7.7 Almac Group
7.7.1 Company profile
7.7.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.7.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Almac Group
7.8 FAMAR Health Care Services
7.8.1 Company profile
7.8.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.8.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services
7.9 Vetter Pharma International GMBH
7.9.1 Company profile
7.9.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.9.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Vetter Pharma International GMBH
7.10 Consort Medical plc
7.10.1 Company profile
7.10.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.10.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Consort Medical plc
7.11 Siegfried Holding AG
7.11.1 Company profile
7.11.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.11.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Siegfried Holding AG
7.12 Boehringer Ingelheim International GmbH
7.12.1 Company profile
7.12.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.12.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim International GmbH
7.13 Evonik Industries AG
7.13.1 Company profile
7.13.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.13.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Evonik Industries AG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
8.1 Industry Chain of Pharmaceutical Contract Development and Manufacturing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
9.1 Cost Structure Analysis of Pharmaceutical Contract Development and Manufacturing
9.2 Raw Materials Cost Analysis of Pharmaceutical Contract Development and Manufacturing
9.3 Labor Cost Analysis of Pharmaceutical Contract Development and Manufacturing
9.4 Manufacturing Expenses Analysis of Pharmaceutical Contract Development and Manufacturing
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pharmaceutical Contract Development and Manufacturing in This Report
1.2 Commercial Types of Pharmaceutical Contract Development and Manufacturing
1.2.1 Pharmaceutical Manufacturing Services
1.2.2 Biologics Manufacturing Services
1.2.3 Drug Development Services
1.3 Downstream Application of Pharmaceutical Contract Development and Manufacturing
1.3.1 Big Pharma
1.3.2 Small Pharma
1.3.3 Generic Pharma
1.3.4 CRO
1.4 Development History of Pharmaceutical Contract Development and Manufacturing
1.5 Market Status and Trend of Pharmaceutical Contract Development and Manufacturing 2013-2023
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Contract Development and Manufacturing 2013-2017
2.2 Production Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Regions
2.3 Demand Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.4 Production and Demand Status of Pharmaceutical Contract Development and Manufacturing by Regions
2.4.1 Production and Demand Status of Pharmaceutical Contract Development and Manufacturing by Regions 2013-2017
2.4.2 Import and Export Status of Pharmaceutical Contract Development and Manufacturing by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Types
3.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Types
3.3 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
4.2 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
5.1 Global Economy Situation and Trend Overview
5.2 Pharmaceutical Contract Development and Manufacturing Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.3 Basic Information of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
6.3.2 Employees and Revenue Level of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 AbbVie Inc.
7.1.1 Company profile
7.1.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.1.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of AbbVie Inc.
7.2 Aenova Group
7.2.1 Company profile
7.2.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.2.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Aenova Group
7.3 Recipharm AB
7.3.1 Company profile
7.3.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.3.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Recipharm AB
7.4 Catalent, Inc.
7.4.1 Company profile
7.4.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.4.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Catalent, Inc.
7.5 Thermo Fisher Scientific Inc.
7.5.1 Company profile
7.5.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.5.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
7.6 Lonza Group Ltd
7.6.1 Company profile
7.6.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.6.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Lonza Group Ltd
7.7 Almac Group
7.7.1 Company profile
7.7.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.7.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Almac Group
7.8 FAMAR Health Care Services
7.8.1 Company profile
7.8.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.8.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services
7.9 Vetter Pharma International GMBH
7.9.1 Company profile
7.9.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.9.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Vetter Pharma International GMBH
7.10 Consort Medical plc
7.10.1 Company profile
7.10.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.10.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Consort Medical plc
7.11 Siegfried Holding AG
7.11.1 Company profile
7.11.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.11.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Siegfried Holding AG
7.12 Boehringer Ingelheim International GmbH
7.12.1 Company profile
7.12.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.12.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim International GmbH
7.13 Evonik Industries AG
7.13.1 Company profile
7.13.2 Representative Pharmaceutical Contract Development and Manufacturing Product
7.13.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Evonik Industries AG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
8.1 Industry Chain of Pharmaceutical Contract Development and Manufacturing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
9.1 Cost Structure Analysis of Pharmaceutical Contract Development and Manufacturing
9.2 Raw Materials Cost Analysis of Pharmaceutical Contract Development and Manufacturing
9.3 Labor Cost Analysis of Pharmaceutical Contract Development and Manufacturing
9.4 Manufacturing Expenses Analysis of Pharmaceutical Contract Development and Manufacturing
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
